Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004395 220001769 1.75 160.4 Curative (C) 2014-06-23 2014-06-23 AML17 TRIAL 01 N 220025965 AML17 TRIAL
220004396 220010881 1.73 78 Curative (C) 2015-10-13 2015-10-13 AML17 TRIAL 1 N 220025966 AML17 TRIAL
220004397 220001770 1.6 null Curative (C) null 2016-05-29 Cytarabine low (10to20mg/m2) IV/SC N N 220025968 CYTARABINE
220004398 220001770 null null Curative (C) null 2013-07-12 AML17 TRIAL N N 220025968 AML17 TRIAL
220004399 220015797 null 70.2 null null 2014-08-19 Cytarabine Low Dose N null 220025971 CYTARABINE
220004400 220015797 null 61.5 Palliative (P) 2018-01-03 2018-01-03 Cytarabine Low Dose null null 220025971 CYTARABINE
220004401 220015797 null 73.4 null 2017-06-07 2017-06-18 Cytarabine low (10to20mg/m2) IV/SC N N 220025971 CYTARABINE
220004402 220015797 1.7 86.8 null 2014-11-25 2014-11-26 Trial Unspecified Y N 220025971 TRIAL
220004403 220015797 1.91 119.8 Curative (C) 2016-09-21 2016-10-14 Trial Unspecified Y N 220025971 TRIAL
220004406 220015798 0 86.8 Disease modification (D) 2013-09-25 2013-09-25 Trial Unspecified Y N 220025983 TRIAL
220004407 220015798 1.63 null Palliative (P) 2015-05-22 2015-05-26 Cytarabine Low Dose 02 N 220025983 CYTARABINE
220004408 220015798 1.68 53 Curative (C) 2014-11-30 2014-12-12 AML17 TRIAL N N 220025983 AML17 TRIAL
220004409 220021191 1.64 62.2 Curative (C) 2017-01-14 2017-01-14 AML17 TRIAL 1 N 220025988 AML17 TRIAL
220004410 220021191 null 64 Palliative (P) 2016-04-22 2016-06-30 LI-1 TRIAL Y N 220025988 TRIAL
220004411 220021191 1.6 75 Palliative (P) 2016-09-01 2016-09-03 Cytarabine low (10to20mg/m2) IV/SC N N 220025988 CYTARABINE
220004412 220022146 null null Curative (C) null 2015-08-30 AML17 TRIAL null null 220025995 AML17 TRIAL
220004413 220022146 null null Curative (C) null 2014-06-12 Cytarabine Low Dose 02 N 220025995 CYTARABINE
220004414 220022146 1.77 null Curative (C) null 2016-03-26 AML17 TRIAL N null 220025995 AML17 TRIAL
220004415 220022146 1.66 78.5 Curative (C) 2015-01-05 2015-01-06 AML17 TRIAL 01 N 220025995 AML17 TRIAL
220004416 220022146 1.77 54.1 Curative (C) 2014-04-04 2014-04-04 Trial Unspecified Y N 220025995 TRIAL
220004417 220001772 1.68 null Palliative (P) 2016-07-13 2016-07-16 CYTARABINE N N 220026006 CYTARABINE
220004418 220001772 1.85 60.5 Disease modification (D) 2017-04-01 2017-04-02 Trial Unspecified Y N 220026006 TRIAL
220004419 220001772 1.78 95.2 Curative (C) 2013-02-06 2013-02-22 Trial Unspecified null N 220026006 TRIAL
220004423 220001774 1.67 79 Not known (9) 2017-07-05 2017-07-07 AML17 TRIAL 01 N 220026015 AML17 TRIAL
220004424 220001775 1.78 88.5 Palliative (P) 2014-05-31 2014-06-05 Cytarabine Low Dose 02 N 220026016 CYTARABINE
220004425 220001775 0 91.9 null 2017-02-27 2017-03-03 Trial Unspecified N N 220026016 TRIAL
220004426 220001775 1.61 null Palliative (P) null 2016-05-17 Cytarabine Low Dose null null 220026016 CYTARABINE
220004427 220001775 null 65.3 Palliative (P) 2016-04-19 2016-04-27 Cytarabine Low Dose N N 220026016 CYTARABINE
220004428 220020266 1.78 89.6 Not known (9) 2016-04-17 2016-04-17 Trial Unspecified 01 N 220026023 TRIAL
220004429 220001776 0 80 Disease modification (D) 2015-04-19 2015-04-19 Cytarabine Intrathecal (any age) N N 220026028 CYTARABINE
220004430 220001776 null 79.8 Adjuvant (A) 2014-06-12 2014-06-21 AML17 TRIAL N N 220026028 AML17 TRIAL
220004431 220001776 1.86 62.1 Curative (C) null 2017-06-26 AML17 TRIAL 02 N 220026028 AML17 TRIAL
220004432 220018657 1.68 null Palliative (P) 2015-11-02 2015-11-02 Cytarabine Low Dose N N 220026033 CYTARABINE
220004433 220018657 1.77 89 Not known (9) 2016-08-31 2016-09-01 AML17 TRIAL 01 N 220026033 AML17 TRIAL
220004436 220001778 null 78.4 Palliative (P) 2014-05-28 2014-05-28 Trial Unspecified 01 N 220026041 TRIAL
220004437 220010889 1.78 102 Palliative (P) 2015-04-28 2015-04-29 Cytarabine low (10to20mg/m2) IV/SC Y N 220026042 CYTARABINE
220004438 220001779 1.65 60 Disease modification (D) 2014-03-07 2014-03-07 Trial Unspecified 01 N 220026043 TRIAL
220004439 220001780 null null Palliative (P) 2014-01-15 2014-01-16 Cytarabine Low Dose null null 220026045 CYTARABINE
220004440 220001781 null 69 null 2013-03-11 2013-03-11 AML17 TRIAL Y N 220026046 AML17 TRIAL
220004441 220010890 1.8 100.4 Curative (C) 2013-06-16 2013-06-21 LI-1 TRIAL N N 220026051 TRIAL
220004442 220010890 null null Not known (9) null 2017-08-29 AML17 TRIAL null null 220026051 AML17 TRIAL
220004443 220010890 null null Palliative (P) 2016-09-09 2016-09-09 Cytarabine Low Dose null null 220026051 CYTARABINE
220004444 220010890 null 46.4 Palliative (P) 2013-11-26 2013-11-26 CYTARABINE 2 null 220026051 CYTARABINE
220004448 220001783 1.83 95 null 2015-06-08 2015-06-08 AML17 TRIAL 02 N 220026066 AML17 TRIAL
220004449 220010892 1.66 114 Palliative (P) 2016-05-03 2016-05-03 CYTARABINE N N 220026067 CYTARABINE
220004450 220015805 null null Palliative (P) null 2017-03-20 Cytarabine Low Dose null null 220026070 CYTARABINE
220004451 220015805 null 90 null 2014-12-28 2014-12-28 Cytarabine Low Dose N N 220026070 CYTARABINE
220004452 220015805 1.87 77.5 null 2016-05-25 2016-05-25 Cytarabine Low Dose N N 220026070 CYTARABINE
220004453 220015805 1.85 43.7 Curative (C) 2014-07-28 2014-07-28 AML17 TRIAL Y N 220026070 AML17 TRIAL
220004454 220001784 1.65 87.7 Curative (C) null 2016-01-11 Trial Unspecified Y null 220026078 TRIAL